If you’re still evaluating whether the Cali Baja biomedical manufacturing corridor deserves a spot on your nearshoring shortlist, you’re asking the wrong question. The question isn’t if, it’s when. Plenty of executives have wondered if the cross-border complexity is worth it—especially when there are simpler options in Eastern Europe or Southeast Asia.
Then they run the numbers. Then they visit. And then they write checks.
When Abbott Laboratories announced its $200 million electrophysiology plant expansion in January, it wasn’t a one-off bet. The Cali Baja region has established itself as a binational mega-region valued at over $250 billion, and if you’re still skeptical about why companies like Medtronic, BD, and Stryker keep expanding here instead of Vietnam or Poland, pay attention to these eight facts. Beyond Borders News
1. It’s a $250 Billion Integrated Mega-region, Not Just a Border Town
The Cali Baja biomedical manufacturing corridor encompasses San Diego and Imperial County in California, along with Baja California in Mexico, forming a 150-mile economic corridor where the border functions less like a barrier and more like a seam connecting two pieces of the same fabric. Beyond Borders News
The Medical Device Cluster of the Californias and the Cali-Baja Biotech Cluster together represent over 850 companies. That’s 850 companies within driving distance of each other, creating ecosystem density where problems get solved over lunch instead of months of email chains. Co-production
2. 74,000 Workers Who Know FDA Regulations Cold
Over 80 major medical device manufacturing companies operate in Baja California, employing more than 74,000 highly skilled workers. These aren’t entry-level assembly workers—they’re technicians who troubleshoot automated optical inspection systems and quality specialists who’ve internalized FDA 21 CFR Part 820. Start-Ops Mexico
Walk into any of Tijuana’s 73 active medical device manufacturing facilities, and you’ll find equipment that would fit seamlessly into a plant in Minnesota. The difference? You’re 30 minutes from San Diego’s R&D labs instead of a 14-hour flight away. KiTalent
3. San Diego’s $56.6 Billion Innovation Engine Powers It All
San Diego is one of the world’s most important biotechnology clusters, and its demand for specialized manufacturing, precision assembly, and regulatory services is supported by Baja California, creating a binational biomedical innovation ecosystem. Beyond Borders News
San Diego directly employed 75,816 workers in life sciences and contributed $56.6 billion in total economic output in 2023. UC San Diego, Scripps Research, the Salk Institute aren’t just academic institutions, they’re prototype factories feeding directly into Tijuana’s production lines. Biocom
When your chief scientist is 30 minutes from the production floor instead of a 14-hour flight away, you solve problems in days, not weeks.
4. Eight New Facilities Opened in Just 12 Months
Between January 2024 and January 2025 alone, eight new greenfield medical device investments arrived in Tijuana. That’s not expansion, it’s eight companies establishing completely new operations. KiTalent
Foreign investment in Mexico‘s medical device sector keeps accelerating because companies run the numbers on USMCA tariffs, calculate lead times versus Asian alternatives, and model what it’s worth to have engineering and production in the same time zone. The Cali Baja biomedical manufacturing corridor wins every time.
5. $3.2 Billion in Exports, 88% Going Straight to U.S. OEMs
The sector exports approximately $3.2 billion annually, with 88% of production flowing directly to U.S. OEMs. These aren’t speculative operations hoping to find customers, they’re fully integrated into U.S. healthcare supply chains. KiTalent
When Medtronic’s coronary devices roll off Tijuana production lines, they’re already allocated to specific hospitals. That level of integration doesn’t happen accidentally, and once it exists, companies don’t casually relocate it. Medical Device manufacturing in Mexico has become too embedded in U.S. healthcare delivery to treat as just another sourcing option.
6. Otay II Port Will Cut Border Crossing Times by 2026-2027
The Otay II project is shaping up to be a key element for 2026 and 2027, with the opening of this new port of entry projected for that period, promising to significantly reduce wait times and divert commercial and private vehicle traffic. Beyond Borders News
For manufacturers, this means faster inventory turns, lower safety stock requirements, and less cash tied up in goods at the border. When you’re managing just-in-time supply chains for medical devices with shelf lives measured in months, every hour matters.
7. The Talent Pipeline Gap Nobody Mentions
Here’s the uncomfortable truth: regional universities produce only 345 biomedical and advanced manufacturing engineering graduates each year, covering roughly 40% of projected technical professional openings. KiTalent
Forty percent of surveyed facilities plan to deploy CNC machine-tending robots by Q2 2026, but those robots need mechatronics engineers to program them. Starting an advanced manufacturing business in Mexico means building your own talent pipeline through university partnerships, not just raiding competitors. KiTalent
Companies succeeding here treat workforce development as strategic investment, not an HR afterthought.
8. Running at 89% Capacity, Space, Not Demand, Is the Constraint
Tijuana’s medical device cluster now operates at roughly 89% capacity. When you’re running that hot, there’s limited flexibility for rapid expansion. KiTalent
This creates opportunity. Demand significantly exceeds supply, which means business opportunities in Mexico exist not just for manufacturers but for developers who can bring new industrial real estate online. Companies now plan 18-24 months ahead for facility availability rather than expecting to move in next quarter.
Ready to Explore the Cali Baja Advantage?
Tijuana EDC has been helping companies successfully establish and expand operations in the Cali Baja corridor for years. Whether you’re evaluating the region for the first time or ready to break ground on your next facility, Tijuana EDC provides the local expertise that turns cross-border complexity into competitive advantage.
From site selection and regulatory compliance to workforce development and supply chain integration, Tijuana EDC connects you with the resources and insights you need to make your Baja California operation a strategic asset—not just a cost center—that accelerates your speed to market.
Contact Tijuana EDC today to schedule a site visit and discover how the Cali Baja biomedical manufacturing corridor can transform your nearshoring strategy from a cost-saving initiative into a competitive advantage that your Asian and European competitors can’t replicate.
You may also like:
